Phenotypic and functional markers for 1alpha,25-dihydroxyvitamin D(3)-modified regulatory dendritic cells.
about
Vitamin D receptor agonists: suitable candidates as novel therapeutic options in autoimmune inflammatory myopathyVitamin D and microRNAs in boneRegulatory dendritic cells in the tumor immunoenvironmentVitamin D every day to keep the infection away?Vitamin D in inflammatory diseases.Exogenous control of the expression of Group I CD1 molecules competent for presentation of microbial nonpeptide antigens to human T lymphocytesNeem leaf glycoprotein partially rectifies suppressed dendritic cell functions and associated T cell efficacy in patients with stage IIIB cervical cancer.From the bench to the clinic: New aspects on immunoregulation by vitamin D analogs.Vitamin D regulates cytokine patterns secreted by dendritic cells to promote differentiation of IL-22-producing T cells.Negative Association of Plasma Levels of Vitamin D and miR-378 With Viral Load in Patients With Chronic Hepatitis B InfectionMicroRNAs implicated in the immunopathogenesis of lupus nephritis.Impact of vitamin D on immune function: lessons learned from genome-wide analysis.Harnessing dendritic cells in inflammatory skin diseases.Vitamin D3: a helpful immuno-modulator.Effects of vitamin D on immune disorders with special regard to asthma, COPD and autoimmune diseases: a short review.Vitamin D receptor agonists target CXCL10: new therapeutic tools for resolution of inflammation.Vitamin D: Immuno-modulation and tuberculosis treatment.Tolerogenic dendritic cells show gene expression profiles that are different from those of immunogenic dendritic cells in DBA/1 mice.Role of vitamin D in cytotoxic T lymphocyte immunity to pathogens and cancer.Vitamin D in rheumatoid arthritis-towards clinical application.The impact of cholecalciferol supplementation on the systemic inflammatory profile: a systematic review and meta-analysis of high-quality randomized controlled trials.The role of UV radiation and vitamin D in the seasonality and outcomes of infectious disease.Topical 1,25-dihydroxyvitamin D3 subverts the priming ability of draining lymph node dendritic cells.Impaired T cell activation and cytokine production by calcitriol-primed human B cells.miR-155 Dysregulation and Therapeutic Intervention in Multiple Sclerosis.Decreased sensitivity to 1,25-dihydroxyvitamin D3 in T cells from the rheumatoid joint.Regulation of CYP27B1 and CYP24A1 hydroxylases limits cell-autonomous activation of vitamin D in dendritic cells.Expression of miR-146a and miR-155 in the urinary sediment of systemic lupus erythematosus.Vitamin D in Human Immunodeficiency Virus Infection: Influence on Immunity and Disease.Comparative transcriptomic profile of tolerogenic dendritic cells differentiated with vitamin D3, dexamethasone and rapamycinSearching for the Transcriptomic Signature of Immune Tolerance Induction-Biomarkers of Safety and Functionality for Tolerogenic Dendritic Cells and Regulatory MacrophagesImmune stimuli shape the small non-coding transcriptome of extracellular vesicles released by dendritic cells
P2860
Q26849424-4F181BDB-393F-4186-9E32-69BAAF3A1C63Q27015808-0154C5FC-1853-48B5-BC92-0E1EA87E5085Q27023084-F5ED655C-4578-4C65-AB9F-C4FB4FCE3CF7Q28081172-E8ACD0E1-08B9-4E12-A3E1-11181B6699E7Q33833563-AE52A464-6888-45DE-9F79-AEBC2572C803Q34983782-45D24E92-0E6B-40EA-B45D-695D357D6CB1Q35066357-2730AF91-95EB-4D31-B2C2-83D9FCC1A03EQ35558877-3DEB2C38-4EE7-4AED-B437-7385C28D4B94Q35673174-E442EC5B-93AF-4655-B368-5C37BECB2D9CQ35942365-9A62E49F-E621-4D3B-8BC5-5FE7DF591BBBQ37090412-3CFCAA19-B9F1-4A5D-A130-D8BE1BF22BCCQ37725587-0C3E087F-0637-49A0-B002-AF4CB4851D95Q37835969-C1F0E27E-0977-49A8-914A-6F1A38115506Q37927252-5C391AA4-01A7-4B7C-A38C-96912E551DD6Q38066985-678D07D8-FEB5-4109-AC8D-262548EC1DABQ38108294-7CD40C87-D43D-4CA0-9B01-C18DA8E1F28FQ38368241-9464AF19-1A4D-40DF-8CC4-543D104B83BCQ38453096-C8CCFD00-FDB8-42FA-B154-26572D12F9D0Q38610901-2610B443-B1EA-44F7-BCB4-DAE93D7CD067Q38611147-EAE3FB13-D767-46FC-96E4-6395E45675ECQ38685735-E92CD50F-E764-40AE-A617-A718F9D87907Q40375467-4FBA5DBA-2669-41A0-A39F-AEDBCA122064Q43012945-05123F62-54FA-4D5E-B911-35C207E78CEDQ45221213-B84831A3-F87C-451D-8EC4-84F1D0232CC1Q48108346-46555A4A-100F-4AAF-A197-E23344C8E5CAQ48621485-45EBD1BF-FA66-4FBB-8D68-C8EE962EA103Q53061723-4AC6A5CD-6C9A-444A-899B-19E611308EC9Q54344450-7947C029-03B5-437E-A3EF-8FE2C2927F41Q55283531-3525E98A-ABC2-4998-BDCA-D6BB3057B6DBQ57296139-C07CAFDC-BF03-4DF3-8537-C51D8B161239Q57300168-ABB80FF7-9D29-4CA4-8630-8D05903EC368Q58223804-E8165805-1220-4914-8FF5-845F5FBA39DA
P2860
Phenotypic and functional markers for 1alpha,25-dihydroxyvitamin D(3)-modified regulatory dendritic cells.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Phenotypic and functional mark ...... ed regulatory dendritic cells.
@en
Phenotypic and functional mark ...... ed regulatory dendritic cells.
@nl
type
label
Phenotypic and functional mark ...... ed regulatory dendritic cells.
@en
Phenotypic and functional mark ...... ed regulatory dendritic cells.
@nl
prefLabel
Phenotypic and functional mark ...... ed regulatory dendritic cells.
@en
Phenotypic and functional mark ...... ed regulatory dendritic cells.
@nl
P2093
P2860
P1476
Phenotypic and functional mark ...... ed regulatory dendritic cells.
@en
P2093
A W Pedersen
K Holmstrøm
M H Claesson
P Kvistborg
S Rasmussen
S S Jensen
P2860
P356
10.1111/J.1365-2249.2009.03961.X
P577
2009-07-01T00:00:00Z